EU health agency urges stepped-up antibiotic resistance fight
The European Union health agency on Monday warned that Europe was set to miss goals on reducing the use of antibiotics, ...
European committee takes a second look at Alzheimer’s drug and now says it should be approved
A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting ...
STAT4d
Changing course, European regulators now say Alzheimer’s treatment Leqembi should be approved
Reversing an earlier decision, European regulators recommended that an Alzheimer’s therapy from Eisai and Biogen should be ...
SNGX: Phase 3 CTCL Trial to Initiate Before End of 2024
SNGX READ THE FULL SNGX RESEARCH REPORT Business Update Phase 3 CTCL Trial to Initiate Before End of 2024 Soligenix, Inc.
European watchdog partially approves new Alzheimer's drug
Europe's medicines watchdog on Thursday partially approved a marketing request for a long-awaited new treatment for Alzheimer ...
EURACTIV13d
European Patients’ Forum developing new patient involvement barometer to improve healthcare
Patient involvement in health policy is a patchwork across the EU. Putting the lived experience front and centre of policy-making was prioritised at a recent high-level policy event organised by the ...
EU regulator backs Eisai-Biogen Alzheimer's drug after initial rejection
The European Union's drugs regulator on Thursday recommended approval for Eisai and Biogen's Leqembi in some patients with ...
Sweden and Finland, wary of war, give new guidance on how to survive one
The two Nordic nations joined NATO after Russia’s invasion of Ukraine. With tensions rising, they are preparing their ...
News2429d
Talks have started to get the twice-yearly anti-HIV jab registered in SA
How EU-M4All works EU-M4all runs at the same time as the European Medicine Agency’s approval process (to save time). This helps countries outside of the European Union to speed up their own checks ...